Research ArticleArticle
Prediction of the Transporter-Mediated Drug-Drug Interaction Potential of Dabrafenib and Its Major Circulating Metabolites
Harma Ellens, Marta Johnson, Sarah K. Lawrence, Cory Watson, Liangfu Chen and Lauren E. Richards-Peterson
Drug Metabolism and Disposition June 2017, 45 (6) 646-656; DOI: https://doi.org/10.1124/dmd.116.073932
Harma Ellens
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, King of Prussia, Pennsylvania
Marta Johnson
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, King of Prussia, Pennsylvania
Sarah K. Lawrence
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, King of Prussia, Pennsylvania
Cory Watson
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, King of Prussia, Pennsylvania
Liangfu Chen
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, King of Prussia, Pennsylvania
Lauren E. Richards-Peterson
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, King of Prussia, Pennsylvania

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Risk for Transporter-Mediated Drug-Drug Interactions for Dabrafenib and Metabolites
Harma Ellens, Marta Johnson, Sarah K. Lawrence, Cory Watson, Liangfu Chen and Lauren E. Richards-Peterson
Drug Metabolism and Disposition June 1, 2017, 45 (6) 646-656; DOI: https://doi.org/10.1124/dmd.116.073932
Research ArticleArticle
Risk for Transporter-Mediated Drug-Drug Interactions for Dabrafenib and Metabolites
Harma Ellens, Marta Johnson, Sarah K. Lawrence, Cory Watson, Liangfu Chen and Lauren E. Richards-Peterson
Drug Metabolism and Disposition June 1, 2017, 45 (6) 646-656; DOI: https://doi.org/10.1124/dmd.116.073932
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement